<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:05:32Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5516167" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5516167</identifier><datestamp>2017-08-02</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
      <journal-id journal-id-type="doi">10.1002/(ISSN)1552-4833</journal-id>
      <journal-id journal-id-type="publisher-id">AJMG</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Medical Genetics. Part a</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1552-4825</issn>
      <issn pub-type="epub">1552-4833</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5516167</article-id>
      <article-id pub-id-type="pmcid">PMC5516167</article-id>
      <article-id pub-id-type="pmc-uid">5516167</article-id>
      <article-id pub-id-type="pmid">27665729</article-id>
      <article-id pub-id-type="doi">10.1002/ajmg.a.37935</article-id>
      <article-id pub-id-type="publisher-id">AJMGA37935</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Clinical Report</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Clinical Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>New <italic>SMARCA2</italic> mutation in a patient with NicolaidesâBaraitser syndrome and myoclonic astatic epilepsy</article-title>
        <alt-title alt-title-type="left-running-head">TANG ET AL</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="ajmga37935-cr-0001" contrib-type="author" corresp="yes">
          <name>
            <surname>Tang</surname>
            <given-names>S.</given-names>
          </name>
          <address>
            <email>shan.tang@kcl.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="ajmga37935-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="ajmga37935-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ajmga37935-cr-0002" contrib-type="author">
          <name>
            <surname>Hughes</surname>
            <given-names>E.</given-names>
          </name>
          <xref ref-type="aff" rid="ajmga37935-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ajmga37935-cr-0003" contrib-type="author">
          <name>
            <surname>Lascelles</surname>
            <given-names>K.</given-names>
          </name>
          <xref ref-type="aff" rid="ajmga37935-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="ajmga37935-cr-0004" contrib-type="author">
          <collab collab-type="authors">EuroEPINOMICS RES myoclonic astatic epilepsy working group</collab>
          <xref ref-type="author-notes" rid="ajmga37935-note-0001">
<sup>â </sup>
</xref>
        </contrib>
        <contrib id="ajmga37935-cr-0005" contrib-type="author">
          <name>
            <surname>Simpson</surname>
            <given-names>M. A.</given-names>
          </name>
          <xref ref-type="aff" rid="ajmga37935-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="ajmga37935-cr-0006" contrib-type="author">
          <name>
            <surname>Pal</surname>
            <given-names>D. K.</given-names>
          </name>
          <xref ref-type="aff" rid="ajmga37935-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="ajmga37935-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="ajmga37935-aff-0001">
<label><sup>1</sup></label>
<institution>King's College London</institution>
<named-content content-type="city">London</named-content>
<country country="GB">United Kingdom</country>
</aff>
      <aff id="ajmga37935-aff-0002">
<label><sup>2</sup></label>
<institution>King's Health Partners</institution>
<named-content content-type="city">London</named-content>
<country country="GB">United Kingdom</country>
</aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>
Correspondence to:<break/>
Dr. Shan Tang, Maurice Wohl Clinical Neuroscience Institute, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.<break/>
Eâmail: 
<email>shan.tang@kcl.ac.uk</email><break/></corresp>
        <fn id="ajmga37935-note-0001">
          <label>â </label>
          <p>Consortia: The members of the myoclonic astatic epilepsy working group are Carla Marini, Renzo Guerrini, Bernd Neubauer, Christian M. Korff, Dana Craiu, Deb Pal, Hande Caglayan, Ingo Helbig, Peter De Jonghe, Rhys Thomas, Rikke S. MÃ¸ller, Sanjay Sisodiya, Sarah von Spiczak, Sarah Weckhuysen, Tiina Talvik.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <volume>173</volume>
      <issue>1</issue>
      <issue-id pub-id-type="doi">10.1002/ajmg.a.v173.1</issue-id>
      <fpage>195</fpage>
      <lpage>199</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 Wiley Periodicals, Inc. <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. <italic>American Journal of Medical Genetics Part A</italic> published by Wiley Periodicals, Inc.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:AJMG-173-195.pdf"/>
      <abstract>
        <p>We report a de novo <italic>SMARCA2</italic> missense mutation discovered on exome sequencing in a patient with myoclonic astatic epilepsy, leading to reassessment and identification of NicolaidesâBaraitser syndrome. This de novo <italic>SMARCA2</italic> missense mutation c.3721C&gt;G, p.Gln1241Glu is the only reported mutation on exon 26 outside the ATPase domain of SMARCA2 to be associated with NicolaidesâBaraitser syndrome and adds to chromatin remodeling as a pathway for epileptogenesis. Â© 2016 The Authors. <italic>American Journal of Medical Genetics Part A</italic> published by Wiley Periodicals, Inc.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="ajmga37935-kwd-0001">SMARCA2</kwd>
        <kwd id="ajmga37935-kwd-0002">myoclonic astatic epilepsy</kwd>
        <kwd id="ajmga37935-kwd-0003">NicolaidesâBaraitser syndrome</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="0"/>
        <page-count count="5"/>
        <word-count count="2839"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>ajmga37935</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>January 2017</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.4 mode:remove_FC converted:19.07.2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <p content-type="self-citation">
<mixed-citation publication-type="journal" id="ajmga37935-cit-000A">
<string-name>
<surname>Tang</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Hughes</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Lascelles</surname>
<given-names>K</given-names>
</string-name>, 
<collab collab-type="authors">EuroEPINOMICS RES myoclonic astatic epilepsy working group</collab>
.
<string-name>
<surname>Simpson</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Pal</surname>
<given-names>DK</given-names>
</string-name>. 
<year>2017</year>
<article-title>New <italic>SMARCA2</italic> mutation in a patient with NicolaidesâBaraitser syndrome and myoclonic astatic epilepsy</article-title>. 
<source>Am J Med Genet Part A</source>
<volume>173A</volume>:<fpage>195</fpage>â<lpage>199</lpage>.
</mixed-citation>
</p>
    </notes>
    <notes>
      <fn-group>
        <fn id="ajmga37935-note-0002">
          <p>Conflict of interest: None.</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <sec id="ajmga37935-sec-0002">
      <title>INTRODUCTION</title>
      <p>Myoclonic astatic epilepsy (MAE), or Doose syndrome, is a genetically heterogenous rare childhood epilepsy syndrome characterized by the onset of myoclonicâatonic or atonic seizures between the ages of 6 months and 6 years in a previously normally developing child [Doose et al., <xref rid="ajmga37935-bib-0004" ref-type="ref">1970</xref>]. Typical febrile seizures may precede afebrile seizures in twoâthirds of cases. Other generalized seizure types are frequently seen and electroencephalogram (EEG) shows generalized spike wave or polyspike discharges on a normal background. Prognosis is variable from complete seizure remission, with normal or close to normal development, to a drugâresistant epileptic encephalopathy. Approximately 10% of cases can be attributed to mutations in <italic>SCN1A</italic>, <italic>SCN1B</italic>, <italic>GABRG2</italic>, <italic>SLC2A1</italic>, <italic>CHD2</italic>, or <italic>SLC6A1</italic>, but the majority of cases remain unexplained [Wallace et al., <xref rid="ajmga37935-bib-0013" ref-type="ref">1998</xref>, <xref rid="ajmga37935-bib-0014" ref-type="ref">2001</xref>; Escayg et al., <xref rid="ajmga37935-bib-0006" ref-type="ref">2001</xref>; Mullen et al., <xref rid="ajmga37935-bib-0007" ref-type="ref">2011</xref>; Carvill et al., <xref rid="ajmga37935-bib-0002" ref-type="ref">2013</xref>; Carvill et al., <xref rid="ajmga37935-bib-0003" ref-type="ref">2015</xref>]. We report a patient with MAE who, following exome sequencing, was subsequently diagnosed with NicolaidesâBaraitser syndrome (NCBRS) (OMIM 601358). NCBRS was first described in 1993 and is an intellectual disability and multiple congenital anomalies syndrome associated with seizures [Nicolaides and Baraitser, <xref rid="ajmga37935-bib-0008" ref-type="ref">1993</xref>]. Although much of the phenotype is well delineated and includes sparse hair, microcephaly, typical facial morphology, brachydactyly, prominent interphalangeal joints, and intellectual disability with marked language impairment, the epilepsy features have not been well described before.</p>
    </sec>
    <sec id="ajmga37935-sec-0003">
      <title>CLINICAL REPORT</title>
      <p>A girl of Ghanaian ancestry was born at term with a birth weight of 3.4âkg (50th centile) and a head circumference of 32âcm (0.4th centile). Her mother reported normal early developmental milestones. She sat unsupported at 8 months, walked at 12 months, and was babbling just before her first birthday. However, her mother had concerns that she had reduced visual interest in people and did not smile readily. Her first seizure was at 14 months and was a myoclonic atonic seizure, which continued as her prominent seizure type while she developed generalized tonicâclonic and absence seizures. Additionally, the patient had feeding problems from 6 months following the introduction of solids. She was hypersensitive to textures and demonstrated food refusal and would hold food in her mouth or vomit during meal times. Developmental assessment showed a delay in language and social communication skills. No dysmorphic features were identified at the time. At 17 months her weight was 10.7âkg (50thâ75th centile), height 82.5âcm (75thâ91st centile), head circumference 48âcm (98thâ99.6th centile). At 2 years 9 months, her weight was 13.9âkg (25thâ50th centile), height 94.7âcm (50thâ75th centile), and she had developed relative microcephaly with her head circumference at 49âcm (9thâ25th centile). Her EEG demonstrated frequent generalized bursts of polyspike and wave activity during wakefulness and sleep against a normal background. An electrographic correlate of negative axial myoclonus was captured (see Supplementary information Figs. S1 and S2). An MRI brain scan was normal. Array CGH analysis with â¼44,000 probes across the genome was normal. Based on these electroclinical features, her epilepsy type was thought compatible with a diagnosis of MAE. She was treated with sodium valproate to which she responded, attaining complete seizure remission at 3 years with normalization of her EEG. Antiepileptic medication was discontinued at 4 years.</p>
      <p>The patient was reviewed at 5 years. She had developed a restricted pattern of feeding with aversion to lumpy foods. The 3Di autism interview revealed abnormalities in communication and nonâverbal communication, with borderline scores in social reciprocity and restricted/repetitive behavior and interests, and she was diagnosed with autism spectrum disorder. On neurodevelopmental assessment with the Wechsler Preschool and Primary Scale of Intelligence III, she demonstrated severe learning difficulties and scored 51 for Verbal IQ (0.1th centile), 57 for Performance IQ (0.2th centile), and 47 for Full Scale IQ (&lt;0.1 centile). Repeat awake and sleep EEG and repeat MRI brain scans were normal.</p>
      <p>Exome sequencing of the patient at the age of 5 years and her parents confirmed paternity and identified a novel de novo <italic>SMARCA2</italic> missense mutation c.3721C&gt;G; p.Gln1241Glu (ENST00000349721 NM_0030703), confirmed by Sanger sequencing in the patient. (See Fig. <xref rid="ajmga37935-fig-0001" ref-type="fig">1</xref>a and b for IGV plot and Sanger sequencing chromatogram, respectively). This novel variant is highly conserved and not reported in 1000G, ExAC, or EVS. In the ExAC database, nonsynonymous missense, stopgain, and splice variants in exon 26 are very rare with MAFâ&lt;â0.0001 and one splice variant with MAF 0.001â0.0001. Annotation from insilico prediction tools was SIFT 0.184 (tolerated), PolyPhen2 0.900 (possibly damaging), mutation taster 0.999 (disease causing), and CADD 22.5 (top 1% most deleterious).</p>
      <fig fig-type="Figure" xml:lang="en" id="ajmga37935-fig-0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>
<bold>a</bold>: IGV plot demonstrating the de novo <italic>SMARCA2</italic> mutation; patient (top), mother (middle), and father (bottom). <bold>b</bold>: Sanger sequencing chromatogram of the patient's <italic>SMARCA2</italic> mutation. [Color figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>].</p>
        </caption>
        <graphic id="nlm-graphic-1" xlink:href="AJMG-173-195-g001">
          <permissions>
            <copyright-holder>Copyright Â© 2016 Wiley Periodicals, Inc.</copyright-holder>
          </permissions>
        </graphic>
      </fig>
      <p>Following the exome sequencing findings, we reviewed her clinical examination at 5 years 5 months and observed skin wrinkling, frontal balding, a broad and long philtrum, broad nasal base, upturned nasal tip, thick alae nasi, anterior projection of the upper lip over the premaxilla, and thin upper vermillion and thick lower vermillion border. She had slightly thick distal phalanges in the hands. (See Fig. <xref rid="ajmga37935-fig-0002" ref-type="fig">2</xref>aâd for clinical photographs). She had eczema particularly involving the elbows and knees. Her clinical phenotype of specific craniofacial features, reduced speech, intellectual disability, autism, and seizures along with a de novo <italic>SMARCA2</italic> mutation was consistent with the NicolaidesâBaraitser syndrome spectrum (NCBRS) [Sousa and Hennekam, <xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>].</p>
      <fig fig-type="Figure" xml:lang="en" id="ajmga37935-fig-0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>
<bold>a</bold> and <bold>b</bold>: Clinical photographs demonstrating features of skin wrinkling, frontal balding, broad nasal base, upturned nasal tip, thick alae nasi, broad and long philtrum, thin upper vermillion, and thick lower vermillion, anterior projection of the upper lip over the premaxilla. <bold>c</bold>: Clinical photographs of hands with slightly thick distal phalanges. <bold>d</bold>: Clinical photograph of feet. [Color figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>].</p>
        </caption>
        <graphic id="nlm-graphic-3" xlink:href="AJMG-173-195-g002">
          <permissions>
            <copyright-holder>Copyright Â© 2016 Wiley Periodicals, Inc.</copyright-holder>
          </permissions>
        </graphic>
      </fig>
      <p>The institutional review boards and ethical committees of King's Health Partners approved the study. The participants gave written informed consent in accordance with the Declaration of Helsinki.</p>
    </sec>
    <sec id="ajmga37935-sec-0004">
      <title>DISCUSSION</title>
      <p>We report a patient with MAE and features of NCBRS. Although seizures are reported in twoâthirds of patients with NCBRS, neither seizure semiology nor specific epilepsy syndromes have been well described. The patient described in this study was diagnosed with MAE syndrome and the diagnosis of NCBRS in this patient was only made following identification of the <italic>SMARCA2</italic> mutation and clinical reâexamination. This was because the NCBRS phenotype is progressive and in younger ages the features are subtle and difficult to recognize. Moreover, there is no reported association between MAE and NCBRS. A specific role for <italic>SMARCA2</italic> mutations has been implicated in NCBRS with at least 80% of patients carrying a mutation in <italic>SMARCA2</italic> (OMIM 601358) [Van Houdt et al., <xref rid="ajmga37935-bib-0012" ref-type="ref">2012</xref>], but to our knowledge all causative mutations have been located in exons 15â25, and never before in exon 26. <italic>SMARCA2</italic> is a chromatin remodeling gene, and mutations in another gene involved in this pathway <italic>CHD2</italic> are known to cause MAE, suggesting this pathway as a potential therapeutic target [Carvill et al., <xref rid="ajmga37935-bib-0002" ref-type="ref">2013</xref>].</p>
      <p>There are no reported specific seizure phenotypes or EEG abnormalities for NCBRS, although epilepsy occurs in twoâthirds of patients. In a series of 61 individuals with NCBRS, the median age at the first seizure was 18 months [Sousa and Hennekam, <xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>]. Additionally, as in our patient, a coâoccurrence of decreasing mental abilities with the onset of seizures (epileptic encephalopathy) in NCBRS has been observed [Sousa and Hennekam, <xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>]. Epileptic encephalopathy is also frequent in MAE, and it is possible that the coâexistence of NCBRS /MAE is more common than expected.</p>
      <p>
<italic>SMARCA2</italic> is located on chromosome 9p24.3 and its longest transcript has 34 exons. Thus far, 62 missense mutations and three inâframe deletions clustering in the ATPase domains of exons 15â25 of <italic>SMARCA2</italic> have been reported in patients with NCBRS [Sousa and Hennekam, <xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>; Bramswig et al., <xref rid="ajmga37935-bib-0001" ref-type="ref">2015</xref>; Ejaz et al., <xref rid="ajmga37935-bib-0005" ref-type="ref">2016</xref>] (see Fig. <xref rid="ajmga37935-fig-0003" ref-type="fig">3</xref> for schematic diagram of SMARCA2 protein and location of mutations). These mutations are thought to have a dominant negative effect by abolishing the ATP hydrolyzing engine potential of the protein, removing the ability of the protein to reposition histones on DNA. Recently, one other patient with NCBRS but no seizures has been reported to carry a mutation c.3655G&gt;C, pAla1219Pro, located outside but close to the ATPase domain, [Bramswig et al., <xref rid="ajmga37935-bib-0001" ref-type="ref">2015</xref>]. To our knowledge, the patient reported here carries the first mutation located in exon 26, also in close proximity of the ATPase domain. We hypothesize that both mutations similarly affect ATP hydrolysis and chromatin remodeling ability. Sousa and Hennekam [<xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>] reported a case with a mutation in the Bromo domain, in exon 30 (p.Gly1420Arg). Their case did not have the typical facial features seen in NCBRS but had overlap features of severe intellectual disability, absent speech and seizures. The absence of mutations reported outside exons 15â25 may be due to restricted diagnostic laboratory sequencing excluding other areas of the gene based on previous association [Sousa and Hennekam, <xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>]. Based on our findings, we would suggest incorporating exon 26 in clinical laboratory testing.</p>
      <fig fig-type="Figure" xml:lang="en" id="ajmga37935-fig-0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Schematic diagram of SMARCA2 protein and its domains and location of missense mutations associated with NCBRS. QLQ, glutamineâleucineâglutamine domain; Proline, prolineârich domain; HSA, small helicase/SANT associated domain; BRK, brahma and kismet domain; SNF2_N and Helicase_C; Bromo, acetylâlysine binding bromodomain. Patient's mutation in black. Mutations reported first by [Van Houdt et al., <xref rid="ajmga37935-bib-0012" ref-type="ref">2012</xref>] in green, [Wolff et al., <xref rid="ajmga37935-bib-0015" ref-type="ref">2012</xref>] in orange, [Sousa and Hennekam, <xref rid="ajmga37935-bib-0010" ref-type="ref">2014</xref>] in blue, [Bramswig et al., <xref rid="ajmga37935-bib-0001" ref-type="ref">2015</xref>] in purple, and [Ejaz et al., <xref rid="ajmga37935-bib-0005" ref-type="ref">2016</xref>] in pink. *Recurrent mutations. **Patient without classical NCBRS but with overlap features of intellectual disability, absent speech and seizures. [Color figure can be viewed at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">wileyonlinelibrary.com</ext-link>].</p>
        </caption>
        <graphic id="nlm-graphic-5" xlink:href="AJMG-173-195-g003">
          <permissions>
            <copyright-holder>Copyright Â© 2016 Wiley Periodicals, Inc.</copyright-holder>
          </permissions>
        </graphic>
      </fig>
      <p>Genetic aberrations involving exon 26 in addition to ATPase disruption have also been described. NCBRS has been reported with a 32âkb de novo inâframe <italic>SMARCA2</italic> deletion affecting exons 20â26 [Wolff et al., <xref rid="ajmga37935-bib-0015" ref-type="ref">2012</xref>] and a 55âkb interstitial deletion involving exons 20â27 was reported in a patient with the phenotypically similar CoffinâSiris syndrome [Tsurusaki et al., <xref rid="ajmga37935-bib-0011" ref-type="ref">2014</xref>]. These patients had epilepsy, but the associated seizure semiology and epilepsy syndromes merit further description.</p>
      <p>
<italic>SMARCA2</italic> is one of the six genes that encodes the catalytic subunit components of the SWItch/sucrose nonfermentable like chromatinâremodeling complex (SWI/SNF complex). The SWI/SNF complex is evolutionarily highly conserved from yeast to humans and works as a chromatin remodeler, altering chromatin structure through ATP hydrolysis. SWI/SNF proteins regulate gene expression by reâpositioning nucleosomes and altering DNA transcription. A close connection between the SWI/SNF complex and neurological development has been implicated through the identification of numerous mutations in genes encoding the subunits in a range of neurodevelopmental disorders such as CoffinâSiris syndrome, sporadic intellectual disability, autism spectrum disorder, schizophrenia, and Kleefstra syndrome [Son and Crabtree, <xref rid="ajmga37935-bib-0009" ref-type="ref">2014</xref>].</p>
      <p>We conclude that (i) NBCRS spectrum features can be caused by mutations outside the ATPase region of <italic>SMARCA2</italic>; and that (ii) the epilepsy phenotype in NBCRS can be consistent with MAE syndrome. This study underlines the fact that, in rare genetically heterogeneous conditions like MAE, where the patient is primarily under the care of a nonâclinical specialist geneticist, exome sequencing can help aid in making clinical syndromic diagnosis.</p>
    </sec>
    <sec id="ajmga37935-sec-0005">
      <title>INTERNET SOURCES</title>
      <p>CADD <ext-link ext-link-type="uri" xlink:href="http://cadd.gs.washington.edu">http://cadd.gs.washington.edu</ext-link>
</p>
      <p>Mutation Taster <ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http://www.mutationtaster.org</ext-link>
</p>
      <p>PolyPhenâ2 <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2">http://genetics.bwh.harvard.edu/pph2</ext-link>
</p>
      <p>SIFT <ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org">http://sift.jcvi.org</ext-link>
</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <p>Additional supporting information may be found in the online version of this article at the publisher's webâsite.</p>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Figure 1</bold>. EEG of patient performed at 17 months demonstrating frequent generalized bursts of polyspike and wave activity during wakefulness against a normal background.</p>
        </caption>
        <media xlink:href="AJMG-173-195-s001.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Figure 2</bold>. EEG of patient at 17 months demonstrating electrographic correlate of negative axial myoclonus with a decrease in EMG signal correlating with an abrupt loss of posture.</p>
        </caption>
        <media xlink:href="AJMG-173-195-s002.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list id="ajmga37935-bibl-0001" content-type="cited-references">
      <title>REFERENCES</title>
      <ref id="ajmga37935-bib-0001">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0001">
<string-name>
<surname>Bramswig</surname>
<given-names>NC</given-names>
</string-name>, 
<string-name>
<surname>LÃ¼decke</surname>
<given-names>HJ</given-names>
</string-name>, 
<string-name>
<surname>Alanay</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Barthelmie</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Boduroglu</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Braunholz</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Caliebe</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Chrzanowska</surname>
<given-names>KH</given-names>
</string-name>, 
<string-name>
<surname>Czeschik</surname>
<given-names>JC</given-names>
</string-name>, 
<string-name>
<surname>Endele</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Graf</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>GuillÃ©nâNavarro</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Kiper</surname>
<given-names>PÃ</given-names>
</string-name>, 
<string-name>
<surname>LÃ³pezâGonzÃ¡lez</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Parenti</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Pozojevic</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Utine</surname>
<given-names>GE</given-names>
</string-name>, 
<string-name>
<surname>Wieland</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Kaiser</surname>
<given-names>FJ</given-names>
</string-name>, 
<string-name>
<surname>Wollnik</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Strom</surname>
<given-names>TM</given-names>
</string-name>, 
<string-name>
<surname>Wieczorek</surname>
<given-names>D</given-names>
</string-name>. 
<year>2015</year>
<article-title>Exome sequencing unravels unexpected differential diagnoses in individuals with the tentative diagnosis of CoffinâSiris and NicolaidesâBaraitser syndromes</article-title>. 
<source>Hum Genet</source>
<volume>134</volume>:<fpage>553</fpage>â<lpage>568</lpage>.
<pub-id pub-id-type="pmid">25724810</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0002">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0002">
<string-name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</string-name>, 
<string-name>
<surname>Heavin</surname>
<given-names>SB</given-names>
</string-name>, 
<string-name>
<surname>Yendle</surname>
<given-names>SC</given-names>
</string-name>, 
<string-name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>O'Roak</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Cook</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Khan</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Dorschner</surname>
<given-names>MO</given-names>
</string-name>, 
<string-name>
<surname>Weaver</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Calvert</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Malone</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Wallace</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Stanley</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Bye</surname>
<given-names>AM</given-names>
</string-name>, 
<string-name>
<surname>Bleasel</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Howell</surname>
<given-names>KB</given-names>
</string-name>, 
<string-name>
<surname>Kivity</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Mackay</surname>
<given-names>MT</given-names>
</string-name>, 
<string-name>
<surname>RodriguezâCasero</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Webster</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Korczyn</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Afawi</surname>
<given-names>Z</given-names>
</string-name>, 
<string-name>
<surname>Zelnick</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Lermanâ Sagie</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Lev</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Moller</surname>
<given-names>RS</given-names>
</string-name>, 
<string-name>
<surname>Gill</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Andrade</surname>
<given-names>DM</given-names>
</string-name>, 
<string-name>
<surname>Freeman</surname>
<given-names>JL</given-names>
</string-name>, 
<string-name>
<surname>Sadleir</surname>
<given-names>LG</given-names>
</string-name>, 
<string-name>
<surname>Shendure</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, 
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, 
<string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>. 
<year>2013</year>
<article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1</article-title>. 
<source>Nat Genet</source>
<volume>45</volume>:<fpage>825</fpage>â<lpage>830</lpage>.
<pub-id pub-id-type="pmid">23708187</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0003">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0003">
<string-name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</string-name>, 
<string-name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</string-name>, 
<string-name>
<surname>Schneider</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Zemel</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Myers</surname>
<given-names>CT</given-names>
</string-name>, 
<string-name>
<surname>Saykally</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Nguyen</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Robbiano</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Zara</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Specchio</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Mecarelli</surname>
<given-names>O</given-names>
</string-name>, 
<string-name>
<surname>Smith</surname>
<given-names>RL</given-names>
</string-name>, 
<string-name>
<surname>Leventer</surname>
<given-names>RJ</given-names>
</string-name>, 
<string-name>
<surname>Moller</surname>
<given-names>RS</given-names>
</string-name>, 
<string-name>
<surname>Nikanorova</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Dimova</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Jordanova</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Petrou</surname>
<given-names>S</given-names>
</string-name>, EuroEPINOMICS Rare Epilepsy Syndrome MyoclonicâAstatic Epilepsy &amp; Dravet working group, 
<string-name>
<surname>Helbig</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Striano</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Weckhuysen</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, 
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, 
<string-name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</string-name>. 
<year>2015</year>
<article-title>Mutations in the GABA transporter SLC6A1 cause epilepsy with MyoclonicâAtonic seizures</article-title>. 
<source>Am J Hum Genet</source>
<volume>96</volume>:<fpage>808</fpage>â<lpage>815</lpage>.
<pub-id pub-id-type="pmid">25865495</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0004">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0004">
<string-name>
<surname>Doose</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Gerken</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Leonhardt</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Volzke</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Volz</surname>
<given-names>C</given-names>
</string-name>. 
<year>1970</year>
<article-title>Centrencephalic myoclonicâastatic petit mal. Clinical and genetic investigations</article-title>. 
<source>Neuropadiatrics</source>
<volume>2</volume>:<fpage>59</fpage>â<lpage>78</lpage>.
</mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0005">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0005">
<string-name>
<surname>Ejaz</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>BabulâHirji</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Chitayat</surname>
<given-names>D</given-names>
</string-name>. 
<year>2016</year>
<article-title>The evolving features of NicolaidesâBaraitser syndromeâA clinical report of a 20âyear followâup</article-title>. 
<source>Clin Case Rep</source>
<volume>28</volume>:<fpage>351</fpage>â<lpage>355</lpage>.
</mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0006">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0006">
<string-name>
<surname>Escayg</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Heils</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>MacDonald</surname>
<given-names>BT</given-names>
</string-name>, 
<string-name>
<surname>Haug</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Sander</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</string-name>. 
<year>2001</year>
<article-title>A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plusâand prevalence of variants in patients with epilepsy</article-title>. 
<source>Am J Hum Genet</source>
<volume>68</volume>:<fpage>866</fpage>â<lpage>873</lpage>.
<pub-id pub-id-type="pmid">11254445</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0007">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0007">
<string-name>
<surname>Mullen</surname>
<given-names>SA</given-names>
</string-name>, 
<string-name>
<surname>Marini</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Suls</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Mei</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Della Giustina</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Buti</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Arsov</surname>
<given-names>T</given-names>
</string-name>, 
<string-name>
<surname>Damiano</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Lawrence</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, 
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, 
<string-name>
<surname>Guerrini</surname>
<given-names>R</given-names>
</string-name>. 
<year>2011</year>
<article-title>Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy</article-title>. 
<source>Arch Neurol</source>
<volume>68</volume>:<fpage>1152</fpage>â<lpage>1155</lpage>.
<pub-id pub-id-type="pmid">21555602</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0008">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0008">
<string-name>
<surname>Nicolaides</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Baraitser</surname>
<given-names>M</given-names>
</string-name>. 
<year>1993</year>
<article-title>An unusual syndrome with mental retardation and sparse hair</article-title>. 
<source>Clin Dysmorphol</source>
<volume>2</volume>:<fpage>232</fpage>â<lpage>236</lpage>.
<pub-id pub-id-type="pmid">8287185</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0009">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0009">
<string-name>
<surname>Son</surname>
<given-names>EY</given-names>
</string-name>, 
<string-name>
<surname>Crabtree</surname>
<given-names>GR</given-names>
</string-name>. 
<year>2014</year>
<article-title>The role of BAF (mSWI/SNF) complexes in mammalian neural development</article-title>. 
<source>Am J Med Genet Part C</source>
<volume>166C</volume>:<fpage>333</fpage>â<lpage>349</lpage>.
<pub-id pub-id-type="pmid">25195934</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0010">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0010">
<string-name>
<surname>Sousa</surname>
<given-names>SB</given-names>
</string-name>, 
<string-name>
<surname>Hennekam</surname>
<given-names>RC</given-names>
</string-name>. 
<year>2014</year>
<article-title>Phenotype and genotype in NicolaidesâBaraitser syndrome</article-title>. 
<source>Am J Med Genet Part C</source>
<volume>166C</volume>:<fpage>302</fpage>â<lpage>314</lpage>.
<pub-id pub-id-type="pmid">25169058</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0011">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0011">
<string-name>
<surname>Tsurusaki</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Ohashi</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Mizuno</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Matsumoto</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Makita</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>Fukuda</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Isidor</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Perrier</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Aggarwal</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Dalal</surname>
<given-names>AB</given-names>
</string-name>, 
<string-name>
<surname>Alâ Kindy</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Liebelt</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Mowat</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Nakashima</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Saitsu</surname>
<given-names>H</given-names>
</string-name>, 
<string-name>
<surname>Miyake</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Matsumoto</surname>
<given-names>N</given-names>
</string-name>. 
<year>2014</year>
<article-title>CoffinâSiris syndrome is a SWI/SNF complex disorder</article-title>. 
<source>Clin Genet</source>
<volume>85</volume>:<fpage>548</fpage>â<lpage>554</lpage>.
<pub-id pub-id-type="pmid">23815551</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0012">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0012">
<string-name>
<surname>Van Houdt</surname>
<given-names>JK</given-names>
</string-name>, 
<string-name>
<surname>Nowakowska</surname>
<given-names>BA</given-names>
</string-name>, 
<string-name>
<surname>Sousa</surname>
<given-names>SB</given-names>
</string-name>, 
<string-name>
<surname>van Schaik</surname>
<given-names>BD</given-names>
</string-name>, 
<string-name>
<surname>Seuntjens</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Avonce</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>Sifrim</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Abdulâ Rahman</surname>
<given-names>OA</given-names>
</string-name>, 
<string-name>
<surname>van den Boogaard</surname>
<given-names>MJ</given-names>
</string-name>, 
<string-name>
<surname>Bottani</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Castori</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>CormierâDaire</surname>
<given-names>V</given-names>
</string-name>, 
<string-name>
<surname>Deardorff</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Filges</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Fryer</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Fryns</surname>
<given-names>JP</given-names>
</string-name>, 
<string-name>
<surname>Gana</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Garavelli</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>GillessenâKaesbach</surname>
<given-names>G</given-names>
</string-name>, 
<string-name>
<surname>Hall</surname>
<given-names>BD</given-names>
</string-name>, 
<string-name>
<surname>Horn</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Huylebroeck</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Klapecki</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>KrajewskaâWalasek</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Lines</surname>
<given-names>MA</given-names>
</string-name>, 
<string-name>
<surname>Maas</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Macdermot</surname>
<given-names>KD</given-names>
</string-name>, 
<string-name>
<surname>McKee</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Magee</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>de Man</surname>
<given-names>SA</given-names>
</string-name>, 
<string-name>
<surname>Moreau</surname>
<given-names>Y</given-names>
</string-name>, 
<string-name>
<surname>MoriceâPicard</surname>
<given-names>F</given-names>
</string-name>, 
<string-name>
<surname>Obersztyn</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Pilch</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Rosser</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Shannon</surname>
<given-names>N</given-names>
</string-name>, 
<string-name>
<surname>StolteâDijkstra</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Van Dijck</surname>
<given-names>P</given-names>
</string-name>, 
<string-name>
<surname>Vilain</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Vogels</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Wakeling</surname>
<given-names>E</given-names>
</string-name>, 
<string-name>
<surname>Wieczorek</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Wilson</surname>
<given-names>L</given-names>
</string-name>, 
<string-name>
<surname>Zuffardi</surname>
<given-names>O</given-names>
</string-name>, 
<string-name>
<surname>van Kampen</surname>
<given-names>AH</given-names>
</string-name>, 
<string-name>
<surname>Devriendt</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Hennekam</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Vermeesch</surname>
<given-names>JR</given-names>
</string-name>. 
<year>2012</year>
<article-title>Heterozygous missense mutations in SMARCA2 cause NicolaidesâBaraitser syndrome</article-title>. 
<source>Nat Genet</source>
<volume>26</volume>:<fpage>445</fpage>â<lpage>459</lpage>.
</mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0013">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0013">
<string-name>
<surname>Wallace</surname>
<given-names>RH</given-names>
</string-name>, 
<string-name>
<surname>Wang</surname>
<given-names>DW</given-names>
</string-name>, 
<string-name>
<surname>Singh</surname>
<given-names>R</given-names>
</string-name>, 
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, 
<string-name>
<surname>George</surname>
<given-names>AL</given-names>
<suffix>Jr.</suffix>
</string-name>, 
<string-name>
<surname>Phillips</surname>
<given-names>HA</given-names>
</string-name>, 
<string-name>
<surname>Saar</surname>
<given-names>K</given-names>
</string-name>, 
<string-name>
<surname>Reis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Johnson</surname>
<given-names>EW</given-names>
</string-name>, 
<string-name>
<surname>Sutherland</surname>
<given-names>GR</given-names>
</string-name>, 
<string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, 
<string-name>
<surname>Mulley</surname>
<given-names>JC</given-names>
</string-name>. 
<year>1998</year>
<article-title>Febrile seizures and generalized epilepsy associated with a mutation in the Na+âchannel beta1 subunit gene SCN1B</article-title>. 
<source>Nat Genet</source>
<volume>19</volume>:<fpage>366</fpage>â<lpage>370</lpage>.
<pub-id pub-id-type="pmid">9697698</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0014">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0014">
<string-name>
<surname>Wallace</surname>
<given-names>RH</given-names>
</string-name>, 
<string-name>
<surname>Marini</surname>
<given-names>C</given-names>
</string-name>, 
<string-name>
<surname>Petrou</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Harkin</surname>
<given-names>LA</given-names>
</string-name>, 
<string-name>
<surname>Bowser</surname>
<given-names>DN</given-names>
</string-name>, 
<string-name>
<surname>Panchal</surname>
<given-names>RG</given-names>
</string-name>, 
<string-name>
<surname>Williams</surname>
<given-names>DA</given-names>
</string-name>, 
<string-name>
<surname>Sutherland</surname>
<given-names>GR</given-names>
</string-name>, 
<string-name>
<surname>Mulley</surname>
<given-names>JC</given-names>
</string-name>, 
<string-name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</string-name>, 
<string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>. 
<year>2001</year>
<article-title>Mutant GABA(A) receptor gamma2âsubunit in childhood absence epilepsy and febrile seizures</article-title>. 
<source>Nat Genet</source>
<volume>28</volume>:<fpage>49</fpage>â<lpage>52</lpage>.
<pub-id pub-id-type="pmid">11326275</pub-id></mixed-citation>
      </ref>
      <ref id="ajmga37935-bib-0015">
        <mixed-citation publication-type="journal" id="ajmga37935-cit-0015">
<string-name>
<surname>Wolff</surname>
<given-names>D</given-names>
</string-name>, 
<string-name>
<surname>Endele</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>AzzarelloâBurri</surname>
<given-names>S</given-names>
</string-name>, 
<string-name>
<surname>Hoyer</surname>
<given-names>J</given-names>
</string-name>, 
<string-name>
<surname>Zweier</surname>
<given-names>M</given-names>
</string-name>, 
<string-name>
<surname>Schanze</surname>
<given-names>I</given-names>
</string-name>, 
<string-name>
<surname>Schmitt</surname>
<given-names>B</given-names>
</string-name>, 
<string-name>
<surname>Rauch</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Reis</surname>
<given-names>A</given-names>
</string-name>, 
<string-name>
<surname>Zweier</surname>
<given-names>C</given-names>
</string-name>. 
<year>2012</year>
<article-title>Inâframe deletion and missense mutations of the Câterminal helicase domain of SMARCA2 in three patients with NicolaidesâBaraitser syndrome</article-title>. 
<source>Mol Syndromol</source>
<volume>2</volume>:<fpage>237</fpage>â<lpage>244</lpage>.
<pub-id pub-id-type="pmid">22822383</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>